Fluidigm: Funding, Investors & Team (Oct 2026)
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.
Fluidigm has raised $250M across 1 funding round on record, the most recent a Post-IPO Equity of $250M announced in Jan 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Fluidigm Company Profile and Key Stats
Latest funding round on record: Jan 2022.
Fluidigm Funding Rounds
Fluidigm Founders and Leadership Team
Contact details for the Fluidigm team: 1 of 1 has an email address on file.
Start 14-day free trial →Fluidigm Funding Compared to Other Biotechnology Startups
Fluidigm's latest round of $250M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Fluidigm in Biotechnology and South San Francisco
Companies Similar to Fluidigm
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Fluidigm Funding FAQs
What does Fluidigm do?
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.
How much funding has Fluidigm raised?
Fluidigm has raised $250M across 1 round on record. The most recent is a Post-IPO Equity of $250M announced in Jan 2022.
When did Fluidigm last raise funding?
Fluidigm's most recent funding round on record is a Post-IPO Equity of $250M, announced in Jan 2022.
Who is the CEO of Fluidigm?
Christopher Linthwaite is listed as CEO at Fluidigm.
Where is Fluidigm headquartered?
Fluidigm is based in South San Francisco, California, United States.
How many employees does Fluidigm have?
Fluidigm is in the 501-1000 employee band.
How does Fluidigm's funding compare to other Biotechnology startups?
Fluidigm's latest round of $250M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Fluidigm Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fluidigm is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.